Destiny Pharma
Brighton
About Destiny Pharma
Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products. Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the drug-resistant bacteria that are at the centre of a global healthcare crisis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $55.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2023)
- Ticker: lse:DEST
- Website: destinypharma.com
- Phone: +441273704499
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/destiny-pharma-117100 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.